Dorsal-ventral patterning of the spinal cord requires Gli3 transcriptional repressor activity

  1. Madelen Persson1,5,
  2. Despina Stamataki2,5,
  3. Pascal te Welscher3,
  4. Elisabet Andersson1,
  5. Jens Böse4,
  6. Ulrich Rüther4,
  7. Johan Ericson1,6, and
  8. James Briscoe2,6
  1. 1Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institute, S-171 77 Stockholm, Sweden; 2Developmental Neurobiology, National Institute for Medical Research, London, NW7 1AA, UK; 3Department of Developmental Biology, Faculty of Biology, Utrecht University, 3584CH Utrecht, The Netherlands; 4Institut für Entwicklungs- und Molekularbiologie der Tiere (EMT), Heinrich-Heine-Universität, 40225 Düsseldorf, Germany

Abstract

Sonic hedgehog (Shh) plays a critical role in organizing cell pattern in the developing spinal cord. Gli proteins are thought to mediate Shh signaling, but their role in directing neural tube patterning remains unclear. Here we identify a role for Gli3 transcriptional repressor activity in patterning the intermediate region of the spinal cord that complements the requirement for Gli2 in ventral regions. Moreover, blocking all Gli responses results in a complete dorsalization of ventral spinal cord, indicating that in addition to the specific roles of Gli2 and Gli3 in the neural tube, there is functional redundancy between Gli proteins. Finally, analysis of Shh/Gli3 compound mutant mice substantiates the idea that ventral patterning may involve a mechanism independent, or parallel, to graded Shh signaling. However, even in the absence of graded Shh signaling, Gli3 is required for the dorsal-ventral patterning of the intermediate neural tube. Together these data raise the possibility that Gli proteins act as common mediators integrating Shh signals, and other sources of positional information, to control patterning throughout the ventral neural tube.

Keywords

Footnotes

  • 5 These authors contributed equally to this work.

  • 6 Corresponding authors.

  • E-MAIL johan.ericson{at}cmb.ki.se; FAX 46-8-30-83-74.

  • E-MAIL james.briscoe{at}nimr.mrc.ac.uk; FAX 44-20-8913-8536.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.243402.

    • Received July 25, 2002.
    • Accepted September 9, 2002.
| Table of Contents

Life Science Alliance